ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 84 filers reported holding ADICET BIO INC in Q3 2023. The put-call ratio across all filers is 7.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $220,545 | -72.4% | 160,905 | -51.1% | 0.00% | – |
| Q2 2023 | $798,992 | -75.2% | 328,908 | -41.1% | 0.00% | -100.0% |
| Q1 2023 | $3,216,362 | +53829.6% | 558,367 | -16.3% | 0.00% | -50.0% |
| Q4 2022 | $5,964 | -99.9% | 667,238 | +71.1% | 0.00% | 0.0% |
| Q3 2022 | $5,545,000 | +106.7% | 389,926 | +112.2% | 0.00% | +100.0% |
| Q2 2022 | $2,682,000 | +70.8% | 183,714 | +133.7% | 0.00% | – |
| Q1 2022 | $1,570,000 | +235.5% | 78,613 | +193.6% | 0.00% | – |
| Q4 2021 | $468,000 | +137.6% | 26,776 | +6.9% | 0.00% | – |
| Q3 2021 | $197,000 | -45.3% | 25,053 | -28.4% | 0.00% | – |
| Q2 2021 | $360,000 | – | 34,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |